UBS wants to make an 'im­pact' with a new fund, shelling out $650M to join MPM

Swiss bank­ing com­pa­ny UBS jumped in­to the deep end of biotech fundrais­ing Wednes­day, pony­ing up more than half a bil­lion dol­lars to­ward new “im­pact” in­vest­ments …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER